CAS 155488-25-8

Urea,N-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-

Description:

The chemical substance known as Urea, N-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]- (CAS number 155488-25-8) is a complex organic compound characterized by its urea functional group, which is linked to a benzodiazepine moiety. This compound features a chiral center, indicated by the (3R) configuration, and contains multiple functional groups, including a pyridine ring and a methylamino group. The presence of these diverse structural elements suggests potential biological activity, possibly as a pharmaceutical agent. The compound's molecular structure may contribute to its solubility, stability, and interaction with biological targets. As with many benzodiazepine derivatives, it may exhibit properties such as anxiolytic, sedative, or anticonvulsant effects, although specific biological activities would require empirical investigation. Safety and handling precautions should be observed due to the potential for toxicity associated with similar compounds.

Formula: C₂₈H₃₀N₆O₃

Synonyms:

• Urea,N-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-,(R)-
• Sograzepide
• Yf 476
• 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
• (R)-1-[2,3-Dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea
• (R)-1-(1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(3-(methylamino)phenyl)urea

Sograzepide

CAS: 155488-25-8

Sograzepide

Purity: ≥95%

Molecular weight: 498.58g/mol

Ref: 54-BUP21554

N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea

Controlled Product

CAS: 155488-25-8

N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea (GZ4081) is a drug that inhibits gastrin secretion by blocking the G protein coupled receptor. It has been shown to be effective in treating cancer and also has an inhibitory effect on tissue samples. GZ4081 has been shown to have long term treatment effects as well as being effective for prognosis. The effective dose of GZ4081 is not yet known but it is believed to be at least 10 times lower than the doses used for other drugs in its class.

Formula: C₂₈H₃₀N₆O₃

Purity: Min. 95%

Molecular weight: 498.58 g/mol

Ref: 3D-FD153499

Sograzepide-d3

Controlled Product

CAS: 155488-25-8

Formula: C₂₈D₃H₂₇N₆O₃

Color and Shape: Neat

Molecular weight: 501.595

Ref: TR-S675802

Sograzepide

Controlled Product

CAS: 155488-25-8

Formula: C₂₈H₃₀N₆O₃

Color and Shape: Neat

Molecular weight: 498.576

Ref: TR-S675800

Sograzepide

CAS: 155488-25-8

Sograzepide (Netazepide) is a gastrin/CCK-B antagonist, inhibits gastrin/CCK-A activity, and can induce regression of type 1 gastric neuroendocrine tumors

Formula: C₂₈H₃₀N₆O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 498.58

Ref: TM-T16906